News & Analysis as of

Clinical Trials › Commercial Marketing

Arnall Golden Gregory LLP

FDA Detects That a Screening Tool for Early Detection of Cancer Types Might Require More Sleuthing

Arnall Golden Gregory LLP on

The Food and Drug Administration recently issued an untitled letter to a medical device company concerning its non-invasive blood test intended for use as a screening tool for the early detection of certain cancer types. FDA...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide